PORTERVILLE DEVELOPMENTAL CENTER — History
CCN 050546 | 3-year financial timeline | COVID resilience: 46/100
🛡️ Public data only — no PHI permitted on this instance.
$194M
Latest Revenue (FY2022)
+3.3%
Revenue CAGR (3yr)
-6.0%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $181M | $173M | $194M | +12.1% | +3.3% |
| Operating Expenses | $183M | $188M | $205M | +9.2% | +5.8% |
| Operating Margin | -1.0% | -8.8% | -6.0% | +32.0% | +0.0% |
| Net Income | $-2M | $-15M | $-12M | +23.7% | +0.0% |
| Licensed Beds | 17 | 17 | 17 | +0.0% | +0.0% |
| Total Patient Days | 86 | nan | 28 | +nan% | -42.9% |
| Medicare Day % | 3% | nan% | 14% | +nan% | +102.4% |
| Medicaid Day % | 97% | nan% | 86% | +nan% | -5.8% |
COVID Impact & Recovery
Resilience Score: 46/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +6.8% ($181M → $194M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+3.3%
This Hospital
+7.6%
State Avg
Latest Margin
-6.0%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $200M | -8.5% |
| FY2024 (proj) | $206M | -10.9% |
| FY2025 (proj) | $212M | -13.4% |